Introduction:
Amgen announced the groundbreaking of its new next-generation biomanufacturing plant with US$200 million at its West Greenwich, Rhode Island (USA) campus.
Features:
The new plant will use Amgen’s proven next-generation biomanufacturing capabilities.
A next-generation biomanufacturing plant incorporates multiple innovative technologies into a single facility.
The plant requires a smaller manufacturing footprint and offers various environmental benefits, including reduced consumption of water and energy and lower levels of carbon emissions.
Within the plant, the equipment is portable, smaller and some components are disposable, which provides greater flexibility and speed when manufacturing different medicines simultaneously.
Next-generation biomanufacturing plant helps to identify the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
The Manufacturing unit is going to be built in 120,000 square foot, and the facility will create nearly 150 additional highly-skilled manufacturing jobs.
It is expected to be operational by 2020.
Specifications:
| Name | Amgen |
| Budget | US$200 Million |
| Location | West Greenwich, Rhode Island |
| Type | Expansion |
| Parties Involved | Amgen |
| Schedule | To be operational by 2020 |
